ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1181

Gains in Cardiovascular Risk Knowledge Through Web Based Educational Intervention for Rheumatoid Arthritis Patients

Meenakshi Jolly1, Courtney O'Brien1, Aman Kugasia2, Anna Gorfin3, Lauren Klebek3, Joshlean Fair3 and Joel Block1, 1Rush University, Chicago, IL, 2Arthritis Clinic of Cypress and Katy, PA, Katy, TX, 3Rush University, Chicago

Meeting: ACR Convergence 2020

Keywords: Comorbidity, education, patient, Myocardial Infarction, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Cardiopulmonary Aspects

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in rheumatoid arthritis (RA). Ischemic heart disease in RA is often silent and precedes myocardial infarction. Patients’ understanding of conventional and RA-specific CVD risks is pivotal to improving CVD mortality in RA. We describe the results evaluating the effectiveness of a web based educational intervention (EI) for RA patients towards improving their CVD risk knowledge.

Methods: 296 consenting RA patients were enrolled through Rush University Rheumatology clinic. All patients completed demographics, Heart Disease Knowledge Questionnaire (HDKQ) and Heart Disease Fact Questionnaire-RA (HDFQ-RA)) at baseline; a higher score on the HDKQ & HDFQ indicates a higher level of knowledge. HDFQ-RA also includes RA specific CVD risk knowledge questions. An educational video was developed specifically for RA patients with emphasis on RA specific CVD risks. Patients in the EI arm (n=150) watched the 28-minute video, followed immediately by HDKQ and HDFQ-RA. All patients (EI and non EI) completed HDKQ and HDFQ-RA at a follow-up visit 3-4 months later.  Medical chart reviews were completed for RA and CVD pertinent data. Correct response ratios (CRR) were obtained for both questionnaires. General linear model (GLM) analyses for repeated measure were used to compare within person changes with time and intervention status (EI or non EI) in CVD risk knowledge. Effect sizes (ES) for improvements were calculated.

Results: Mean age was 56.5±13.9 years, and 86% were women. 42% were Caucasians, and 40% were African American. There were no differences in EI or non EI group by age, gender, race, education, smoking, hypertension, dyslipidemia, diabetes, body mass index, disease activity or current use of steroids.

Mean (SD) CRR for HDKQ and HDFA-RA for 296 patients at baseline were 0.59 (0.18) and 0.76 (0.17) respectively. Summary scores for HDKQ and HDFA-RA at baseline, post intervention and 3 month follow up stratified by the study intervention group are shown in Table 1. Patients in the EI arm had significantly higher CRR on HDKQ than those in the non EI at baseline (p 0.007). Improvements in HDKQ were observed at 3 months in both EI (ES 0.35) and non EI (0.25) groups. Only within person changes in HDKQ were observed as significant on GLM. Large improvements were seen in the EI group on HDFQ-RA immediately post EI (ES 0.64), and the improvement in CVD risk knowledge was retained at 3 months post EI follow up (ES 0.48). There were no significant improvements noted in HDFQ-RA in non EI group patients at 3 months (ES 0.09). GLM showed both within (time) and between person changes (EI or non EI) to be significant with HDFQ-RA (Figure 1).

Conclusion: Large improvements in CVD risk knowledge (HDFA-RA) were observed among the patients who watched the educational intervention that specifically focused on RA related CVD risks, and the benefits were retained at 3 months. As expected, some improvements in CVD risk knowledge (HDKQ) were observed with time in both groups, as participation in the study and completion of the CVD risk questionnaires alone may have primed the participant’s interest in the topic.

Table 1

Figure 1


Disclosure: M. Jolly, PFIZER, 2, CELGENE, 7, BI, 7, BMS, 7, AURINIA, 7, EVIDERA, 7, LUCIN, 5; C. O'Brien, None; A. Kugasia, None; A. Gorfin, None; L. Klebek, None; J. Fair, None; J. Block, None.

To cite this abstract in AMA style:

Jolly M, O'Brien C, Kugasia A, Gorfin A, Klebek L, Fair J, Block J. Gains in Cardiovascular Risk Knowledge Through Web Based Educational Intervention for Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/gains-in-cardiovascular-risk-knowledge-through-web-based-educational-intervention-for-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gains-in-cardiovascular-risk-knowledge-through-web-based-educational-intervention-for-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology